NCT01478620View on ClinicalTrials.gov

Safety and Efficacy of Canephron® N in the Management of Uncomplicated Urinary Tract Infections (uUTI)

PHASE3CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2012

Study Completion Date

August 31, 2012

Conditions
Urinary Tract Infection
Interventions
DRUG

Canephron® N

3x 2 coated tablets/day for 7 days p.o.

Trial Locations (1)

04107

Kiev Regional City Hospital, Kiev

Sponsors

Lead Sponsor

Bionorica SE
All Listed Sponsors
lead

Bionorica SE

INDUSTRY